Cloud Banner

Press Release

Apr, 17 2023

Beliefs and Trends of Aesthetic Surgery in Young Adults Drives the Demand for the Europe Medical Aesthetics Market

Minimally invasive surgery is procedure conducted with the assistance of a scope of viewing and specially equipped surgical instruments. This is the reason that minimally invasive procedures allow no cuts or minimal cuts with lesser recovery time that allows the increasing demand and use of minimally invasive procedures. Other reasons for the rising of procedures can be defined by the increasing aging people and the requirement for healthcare facilities including patient friendly techniques whose medical requirements are maximum which can further result in decrease burden over healthcare facilities.

Access Full Report @ https://www.databridgemarketresearch.com/reports/europe-medical-aesthetics-market

Reasons for MIS development are heterogeneous and, in some way, interconnected: reduction of patient’s surgical stress, reduced postoperative pain, early return to regular activities, cosmetic advantages, the human innate propensity to innovation among surgeons, industries and economic factors.

An increasing trend of population will lead towards reduction of patients that stays in hospitals in healthcare that further result in, increasing number of surgeries performed. Minimally invasive surgery has very high patient-acceptance growth rate.

Data Bridge Market Research analyses that the medical aesthetics research products is expected to grow at a CAGR of 11.4% in the forecast period of 2023 to 2030 and is expected to reach USD 8,370.03 million by 2030. 

Europe Medical Aesthetics Market

Increasing Funding Activities for Aesthetic Research

Plastic surgery, unwanted hair removal, skin tightening anti-aging, excess fat removal, body contouring, and several other cosmetic procedures are performed through minimally invasive procedures followed under medical aesthetic devices that are used for increasing appearances, beautification, and other improvements to parts of the body. Various foundations and government organizations are investing a large amount in aesthetic research.

As the market players are constantly engaged in research and developmental activities, more hybrid and natural medical aesthetics are being introduced in the Europe medical aesthetics research products market. This would increase the demand for medical aesthetics therapeutics to treat skin problems in hospitals and diagnostic centers. Hence the advancements in research and development activities and increasing investments in pharmaceutical sector is expected to act as a driver for the overall market growth.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customisable to 2015-2020)

Quantitative Units

Revenue in USD Million, Pricing in USD

Segments Covered

By Products (Non-Energy Based Aesthetics Devices, Energy-Based Medical Aesthetics), By Raw Material (Polymers, Metals, Ceramics, Silicon, Resin Composites, Titanium, Others), By Procedure (Cosmetic Procedure, Reconstruction Procedure), By Patient Type (Male, Female), By End User (Dermatology Clinics, Cosmetic Centres, Hospital, Clinics, Medical Spas And Beauty Centres, Homecare, Academic And Research Institutes, Others), By Distribution Channel (Direct Tender, Retail Sales, Others)

Countries Covered

Germany, France, U.K., Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium, Luxembourg, Rest of Europe

Market Players Covered

Mentor Worldwide LLC, Allergan, Cutera, Cynosure, Alma Lasers, Medytox, SharpLight Technologies Inc., Quanta System, Candela Corporation, BTL, Lumenis Be Ltd., 3M, Dentsply Sirona, Institut Straumann AG, GALDERMA, Nobel Biocare Services AG, BioHorizons, MEGA’GEN IMPLANT CO., LTD., Sciton, Merz Pharma, Inc. among others

Data Points Covered in the Report

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, value and supply chain analysis, business strategy excellence, the strength of product portfolio, technological trends, case studies and regulatory framework.

Segment Analysis:

The medical aesthetics research products market is categorized into five notable segments such as product, indication, application, end user and distribution channel.

  • On the basis of product, the Europe medical aesthetics market is segmented into energy-based medical aesthetics and non-energy based aesthetic devices.

In 2023, non-energy based aesthetic devices segment is expected to dominate the Europe medical aesthetics market

In 2023, non-energy based aesthetic devices segment is expected to dominate the Europe medical aesthetics market with 58.37% market share due to growing prevalence of minimally invasive procedures.

  • On the basis of raw materials, the Europe medical aesthetics market is segmented into polymers, metals, ceramics, resin composite, silicon, titanium others. In 2023, polymers segment is expected to dominate the Europe medical aesthetics market with 46.54% market share due to increasing awareness towards cosmetic surgeries.
  • On the basis of procedure, the Europe medical aesthetics market is segmented into cosmetic procedures and reconstruction procedure. In 2023, cosmetic procedure segment is expected to dominate the Europe medical aesthetics market with 66.45% market share due to beliefs and trends of aesthetic surgery in young adults.
  • On the basis of patient type, the Europe medical aesthetics market is segmented into male and female. In 2023, the female segment is expected to dominate the Europe medical aesthetics market with 66.38 % market share due to increasing awareness towards cosmetic surgeries.
  • On the basis of end user, the Europe medical aesthetics market is segmented into hospitals, clinics, dermatology clinics, academic and research institutes, cosmetic centers, homecare, medical spas and beauty centers and others. In 2023, the dermatology clinics segment is expected to dominate the Europe medical aesthetics market with 28.21% market share due to technological advancements in aesthetics and cosmetics procedures.
  • On the basis of distribution channel, the Europe medical aesthetics market is segmented into direct tender, retail sales and others. In 2023, the direct tender segment is expected to dominate the Europe medical aesthetics market with 50.21% market share due to increasing funding activities for aesthetic research.

Mentor Worldwide LLC, Allergan, Cutera, Cynosure, Alma Lasers, Medytox, SharpLight Technologies Inc., Quanta System, Candela Corporation, BTL, Lumenis Be Ltd., 3M, Dentsply Sirona, Institut Straumann AG, GALDERMA, Nobel Biocare Services AG, BioHorizons, MEGA’GEN IMPLANT CO., LTD., Sciton, Merz Pharma, Inc. among others are engaged in the development of medical aesthetics research products for the hospitals, clinical testing laboratory, research centers, pharmaceutical and biotechnology company and academic institution.

Major Players

Data Bridge Market Research recognizes the following companies as the major medical aesthetics research products market players in Europe medical aesthetics market products market are Mentor Worldwide LLC (U.S.), Allergan (Ireland), Cutera (U.S.), Cynosure (U.S.), Candela Corporation (U.S.) Medytox (South Korea), SharpLight Technologies Inc. (Israel), Quanta System (Italy), Alma Laser (Israel), BTL (U.S.), Lumenis Be Ltd. (Israel), 3M (U.S.), Dentsply Sirona (U.S.), Institut Straumann AG (Switzerland), GALDERMA (Switzerland), Nobel Biocare Services AG (Switzerland), BioHorizons (U.S.), MEGA’GEN IMPLANT CO., LTD. (Korea), Sciton (U.S.), and Merz Pharma (Germany).

Europe Medical Aesthetics Market

Market Development

  • In February 2022, Allergan (a subsidiary of AbbVie Inc.) has announced the FDA approval of JUVÉDERM VOLBELLA XC for improvement of infraorbital hollows in adult’s age above 21. This helped the company to expand the product portfolio of aesthetics in the U.S. market
  • In January 2022, Mentor Worldwide LLC (a subsidiary of the Johnson & Johnson Medical Devices Companies) announced that the FDA had approved the MENTOR MemoryGel BOOST breast implant for breast augmentation and breast reconstruction.  This product has helped the company to expand the product portfolio of aesthetics in the U.S. market
  • In January 2021, Candela, a leading global medical aesthetic device company, announced the availability of the Frax Pro system, which is an FDA-cleared, non-ablative fractional device skin resurfacing with both Frax 1550 and the novel Frax 1940 applicators. This helped the company to expand the product portfolio of aesthetics in the global market
  • In November 2019, Lumenis announced its acquisition with the Baring Private Equity Asia (BPEA), a leading provider of specialty energy-based medical-based devices across the field of aesthetics. This shows the company is held by strong support within the aesthetics market for the product portfolio
  • In September 2018, BioHorizons acquired Intra-Lock, a dental implant company based in Boca Raton, Florida. BioHorizons always strives for continuous improvement and with Intra-Lock's products and technology. In particular, the company was excited to add the IntraSpin system to their portfolio since platelet-rich fibrin (PRF) is increasingly used in grafting procedures. This has helped company to enhance their product portfolio in the market

Regional Analysis

Geographically, the countries covered in the Europe medical aesthetics market report are, Germany, France, U.K., Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium, Luxembourg and Rest of Europe.

As per Data Bridge Market Research analysis:

Germany is the dominant Country in Europe medical aesthetics market during the forecast period 2023 - 2030

In 2023, Germany dominated the medical aesthetics research products market owing to the higher level of investments by U.S. manufacturers and increasing prevalence of chronic disorders in Germany will continue to dominate the medical aesthetics research products market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the growing adoption of advanced technology and launch of new products in this region. Additionally, the increasing awareness towards cosmetic surgeries are expected to further enhance the market's growth rate in this region. 

For more detailed information about this market report, click here – https://www.databridgemarketresearch.com/reports/europe-medical-aesthetics-market


Client Testimonials